Netherlands vs South Africa: Number of isolates tested for ceftriaxone
Netherlands
332
in 2020
South Africa
316
in 2020
Netherlands rank
9th
South Africa rank
10th
Number of isolates tested for ceftriaxone over time
- Netherlands
- South Africa
How they compare
Netherlands currently reports 332 against 316 in South Africa, a difference of 16.
That makes Netherlands's figure about 1.1 times South Africa's.
The two have swapped places 2 times across 6 shared years of data; in 2011 it was Netherlands ahead.
Netherlands ranks 9th and South Africa ranks 10th of 52 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 283.2 | 216.6 | 66.6 | Netherlands |
| 2020s | 332 | 316 | 16 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Netherlands or South Africa?
- Netherlands, at 332 against 316 in South Africa as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Netherlands and South Africa?
- 16, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and South Africa?
- 6 years are reported by both, from 2011 to 2020.
- How do Netherlands and South Africa rank globally for number of isolates tested for ceftriaxone?
- Netherlands ranks 9th and South Africa ranks 10th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.